PRLD vs. NIC
PRLD (Prelude Therapeutics Incorporated) and NIC (Nicolet Bankshares Inc.) are both stocks. PRLD operates in Biotechnology (Healthcare), while NIC operates in Banks - Regional (Financial Services). Over the past 5 years, PRLD returned -34.33%/yr vs 11.81%/yr for NIC. At a 0.18 correlation, their price movements are largely independent.
Performance
PRLD vs. NIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRLD achieves a 26.21% return, which is significantly higher than NIC's 9.21% return.
PRLD
- 1D
- 4.57%
- 1M
- -22.78%
- YTD
- 26.21%
- 6M
- 165.22%
- 1Y
- 291.32%
- 3Y*
- -13.68%
- 5Y*
- -34.33%
- 10Y*
- —
NIC
- 1D
- -4.11%
- 1M
- -8.82%
- YTD
- 9.21%
- 6M
- 3.05%
- 1Y
- 10.71%
- 3Y*
- 25.91%
- 5Y*
- 11.81%
- 10Y*
- 13.71%
PRLD vs. NIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PRLD Prelude Therapeutics Incorporated | 26.21% | 127.45% | -70.14% | -29.30% | -51.49% | -82.60% | 173.09% |
NIC Nicolet Bankshares Inc. | 9.21% | 16.76% | 31.91% | 1.93% | -6.95% | 29.24% | 21.14% |
Correlation
The correlation between PRLD and NIC is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Sep 28, 2020 | 0.18 |
The correlation between PRLD and NIC shifts across timeframes, from 0.10 (1 year) to 0.21 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
PRLD:
-$1.05
NIC:
$11.59
PRLD:
16.29
NIC:
2.62
PRLD:
$16.72M
NIC:
$579.85M
PRLD:
$11.30M
NIC:
$296.00M
PRLD:
-$82.17M
NIC:
$151.89M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRLD vs. NIC — Risk / Return Rank
PRLD
NIC
PRLD vs. NIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and Nicolet Bankshares Inc. (NIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRLD | NIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.13 | ||
| Sortino ratioReturn per unit of downside risk | +2.50 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.09 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 4.19 | 0.60 | +3.59 |
| Martin ratioReturn relative to average drawdown | 8.98 | 1.36 | +7.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PRLD | NIC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.48 | 0.34 | +1.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.28 | 0.39 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.45 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.24 | 0.48 | -0.72 |
Drawdowns
PRLD vs. NIC - Drawdown Comparison
The maximum PRLD drawdown since its inception was -99.33%, which is greater than NIC's maximum drawdown of -44.31%. Use the drawdown chart below to compare losses from any high point for PRLD and NIC.
Loading charts...
Drawdown Indicators
| PRLD | NIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.33% | -44.31% | -55.02% |
Max Drawdown (1Y)Largest decline over 1 year | -70.10% | -17.90% | -52.20% |
Max Drawdown (3Y)Largest decline over 3 years | -90.42% | -21.73% | -68.69% |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | -44.31% | -54.11% |
Max Drawdown (10Y)Largest decline over 10 years | — | -44.31% | — |
Current DrawdownCurrent decline from peak | -96.01% | -17.90% | -78.11% |
Average DrawdownAverage peak-to-trough decline | -85.17% | -11.19% | -73.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.62% | 7.90% | +24.72% |
Volatility
PRLD vs. NIC - Volatility Comparison
Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 17.75% compared to Nicolet Bankshares Inc. (NIC) at 8.10%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than NIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRLD | NIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.75% | 8.10% | +9.65% |
Volatility (6M)Calculated over the trailing 6-month period | 88.07% | 22.71% | +65.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 198.96% | 31.26% | +167.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 125.28% | 30.43% | +94.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 122.16% | 30.94% | +91.22% |
Dividends
PRLD vs. NIC - Dividend Comparison
PRLD has not paid dividends to shareholders, while NIC's dividend yield for the trailing twelve months is around 1.00%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
NIC Nicolet Bankshares Inc. | 1.00% | 1.02% | 1.04% | 0.93% |
PRLD Prelude Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PRLD vs. NIC - Financials Comparison
This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and Nicolet Bankshares Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PRLD and NIC have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRLD has higher volatility (17.75%) compared to NIC (8.10%). In terms of maximum drawdown, PRLD dropped -99.33% vs NIC's -44.31%.
PRLD currently has the higher Sharpe Ratio (1.48 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRLD and NIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer